Metformin Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Metformin Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING

BOXED WARNING

PRECAUTIONS
PRECAUTIONS
PRECAUTIONS

CONTRAINDICATIONSPRECAUTIONS

METFORMIN HYDROCHLORIDE DESCRIPTION


Metformin Hydrochloride












CLINICAL PHARMACOLOGY

Mechanism of Action
PRECAUTIONS

PHARMACOKINETICS

Absorption and Bioavailability






Distribution


Metabolism and Elimination


Special Populations




Renal Insufficiency
WARNINGS

Hepatic Insufficiency


Geriatrics
WARNINGSDOSAGE AND ADMINISTRATION


Subject Groups: MetforminCmax(Tmax(hrs)Renal ClearanceHydrochloride Tablet dose*(mL/min)(number of subjects)Healthy, nondiabetic adults:Adults with type 2 diabetes:Elderly#, healthy nondiabetic adults:Renal-impaired adults:850 mg single dose*





#


Pediatrics


Gender


Race


Clinical Studies

Metformin hydrochloride tablets



Metformin Hydrochloride TabletsPlacebop-Value(n = 141)(n = 145)FPG (mg/dL)Hemoglobin Alc (%)Body Weight (lbs)


CombGlybMetGlybp-values(n = 213)(n = 209)(n = 210)CombMet vsMet vsCombGlybFasting Plasma Glucose (mg/dL)Hemoglobin Alc (%)Body Weight (lbs)



Metformin HClCombined MetforminTablets (n = 141)Hydrochloride Tablets/Glyburide vs MonotherapyMetforminPlac- Metformin HydrochlorideMetforminGlyb-HydrochlorideeboTablets (n = 210)HydrochlorideurideTablets (n = 141)(n=Tablets/ Glyburide(n =145)(n = 213)209)TotalCholesterol(mg/dL)TotalTriglycerides(mg/dL)LDLCholesterol(mg/dL)HDL-Cholesterol(mg/dL)



Metformin Hydrochloride Placebo / InsulinTreatment DifferenceTablets / Insulinn = 28MeanSEn = 26Hemoglobin Alc (%)*Insulin Dose (U/day)*





Metformin hydrochloride extended-release tablets




DOSAGE AND ADMINISTRATION


*
Metformin Hydrochloride Metformin Hydrochloride ExtendedTablets 500 mg Twice- release TabletsDaily1000 mg Once Daily1500 mgOnce DailyHemoglobinA1c (%)(n= 67)(n= 72)(n=66)FPG (mg/dL)(n = 69)(n = 72)(n = 70)Body Weight(n = 71)(n = 74)(n = 71)(lbs)*

DOSAGE AND ADMINISTRATION


*
Metformin Hydrochloride Extended-Placebo-release Tablets500 mg Once Daily1000150020001000mgmgmgmgOnceOnceOnceTwiceDailyDailyDailyDailyTotal Cholesterol(n=120)(n=(n=(n=(n=(n=(mg/dL)113)110)126)117)110)Total Triglycerides(n=120)(n=(n=(n=(n=(n=(mg/ dL)113)110)126)117)110)LDL- Cholesterol(n=119)(n=(n=(n=(n=(n=(mg/ dL)113)109)126)117)107)HDLCholesterol(n=120)(n=(n=(n=(n=(n=(mg/dL)108)108)125)117)108)*



*
MetforminMetformin Hydrochloride ExtendedHydrochloride-release TabletsTablets500 mg1000 mg1500 mgTwice DailyOnce DailyOnce DailyTotal Cholesterol (n=68)(n=70)(n=66)(mg/dL)Total Triglycerides (n = 68)(n=70)(n=66)(mg/dL)LDL- Cholesterol (n=68)(n=70)(n=66)(mg/dL)HDL -Cholesterol(n=68)(n=70)(n=65)(mg/dL)*

Pediatric Clinical Studies



Metformin Hydrochloride TabletsPlacebop- ValueFPG (mg/dL)(n=37)(n=36)Body Weight (lbs)(n=39)(n=38)


INDICATIONS & USAGE




METFORMIN HYDROCHLORIDE CONTRAINDICATIONS


WARNINGSPRECAUTIONS


PRECAUTIONS

WARNINGS

BOXED WARNING

PRECAUTIONS
PRECAUTIONS
PRECAUTIONS

CONTRAINDICATIONSPRECAUTIONS

PRECAUTIONS

General

WARNINGSDOSAGE AND ADMINISTRATION

PRECAUTIONS
CONTRAINDICATIONS




PRECAUTIONSLaboratory Tests

WARNINGS





INFORMATION FOR PATIENTS

Information for Patients

WARNINGSPRECAUTIONS

Patient Information


LABORATORY TESTS

Laboratory Tests
DOSAGE AND ADMINISTRATION


DOSAGE AND ADMINISTRATION







CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY

Carcinogenesis, Mutagenesis, Impairment of Fertility




PREGNANCY

Teratogenic Effects: Pregnancy Category B



NURSING MOTHERS



PEDIATRIC USE

Pediatric Use
CLINICAL PHARMACOLOGYADVERSE REACTIONSDOSAGE AND ADMINISTRATION


METFORMIN HYDROCHLORIDE ADVERSE REACTIONS

Geriatric Use
CONTRAINDICATIONSWARNINGSCLINICAL PHARMACOLOGYWARNINGSDOSAGE AND ADMINISTRATION


METFORMIN HYDROCHLORIDE ADVERSE REACTIONS

ADVERSE REACTIONS


*
Adverse ReactionMetformin Hydrochloride TabletsPlaceboMonotherapy n = 141n = 145% of Patients*




*
Adverse ReactionMetformin Hydrochloride Extended-Placebo- release Tablets n = 781n = 195% of Patients*



Pediatric Patients



OVERDOSAGE

WARNINGS

DOSAGE & ADMINISTRATION






Patient Information

Recommended Dosing Schedule


CLINICAL PHARMACOLOGY
CLINICAL PHARMACOLOGY





CLINICAL PHARMACOLOGY




Specific Patient Populations


WARNINGS

HOW SUPPLIED




























STORAGE AND HANDLING





SPL PATIENT PACKAGE INSERT




What are metformin hydrochloride tablets and metformin hydrochloride extended-release tablets?





Who should not take metformin hydrochloride tablets and metformin hydrochloride extended-release tablets?


  • ●have kidney problems
  • ●have liver problems
  • ●have heart failure that is treated with medicines, such as Lanoxin(digoxin) or Lasix(furosemide)
  • ●drink a lot of alcohol. This means you binge drink for short periods or drink all the time
  • ●are seriously dehydrated (have lost a lot of water from your body)
  • ●are going to have an x-ray procedure with injection of dyes (contrast agents)
  • ●are going to have surgery
  • ●develop a serious condition, such as heart attack, severe infection, or a stroke
  • ●are 80 years or older and you have NOT had your kidney function tested
  • ●Tell your doctor if you are pregnant or plan to become pregnant. Metformin hydrochloride tablets and metformin hydrochloride extended-release tablets may not be right for you. Talk with your doctor about your choices. You should also discuss your choices with your doctor if you are nursing a child.
Can metformin hydrochloride tablets or metformin hydrochloride extended-release tablets be used in children?



How should I take metformin hydrochloride tablets or metformin hydrochloride extended-release tablets?






  • ●start to take other medicines or change how you take a medicine. Metformin hydrochloride tablets or metformin hydrochloride extended-release tablets canaffect how well other drugs work, and some drugs can affect how well metformin hydrochloride tablets or metformin hydrochloride extended-release tablets work. Some medicines may cause high blood sugar.
What should I avoid while taking metformin hydrochloride tablets or metformin hydrochloride extended-release tablets?


What are the side effects of metformin hydrochloride tablets and metformin hydrochloride extended-release tablets?






  • ●trouble breathing
  • ●unusual or unexpected stomach discomfort
  • ●feeling cold
  • ●feeling dizzy or lightheaded
  • ●suddenly developing a slow or irregular heartbeat
  • ●If your medical condition suddenly changes, stop taking metformin hydrochloride tablets or metformin hydrochloride extended-release tablets and call your doctor right away. This may be a sign of lactic acidosis or another serious side effect.
  • ●Other Side Effects. Common side effects of metformin hydrochloride tablets and metformin hydrochloride extended-release tablets include diarrhea, nausea, and upset stomach. These side effects generally go away after you take the medicine for a while. Taking your medicine with meals can help reduce these side effects. Tell your doctor if the side effects bother you a lot, last for more than a few weeks, come back after they've gone away, or start later in therapy. You may need a lower dose or need to stop taking the medicine for a short period or for good.

















INACTIVE INGREDIENT

INACTIVE INGREDIENTS

HYPROMELLOSE

MAGNESIUM STEARATE
POLYETHYLENE GLYCOLP
OVIDONE

CELLULOSE, MICROCRYSTALLINE

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Metformin Hydrochloride



Metformin Hydrochloride




Metformin Hydrochloride

Metformin Hydrochloride TABLET, FILM COATED

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-232(NDC:68382-030)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
METFORMIN HYDROCHLORIDE METFORMIN 1000 mg

Inactive Ingredients

Ingredient Name Strength
HYPROMELLOSES
MAGNESIUM STEARATE
polyethylene glycol
povidone
cellulose, microcrystalline

Product Characteristics

Color Size Imprint Code Shape
white 19 mm Z;71 OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-232-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077064 2011-04-29


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.